HIV protease inhibitor and cytochrome p450 inhibitor combinations
US8673970B2 · kind B2 · utility
3Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2009 |
| Grant date | Mar 18, 2014 |
| Priority date | — |
| Expiry date | Dec 22, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods of treating viral infections are provided. More particularly, compositions including a combination of protease inhibitors and cytochrome p450 enzyme inhibitors are provided. Methods of using the compositions for treatment of diseases or disorders caused by a virus such as HIV infections are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.